FDA approves Sanofi's factor VIII hemophilia A drug
Sanofi nabbed an FDA approval for its new hemophilia A therapy, efanesoctocog alfa, on Wednesday evening, according to FDA
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
